MedTrace Logo

Adverse Outcomes and Mortality in Liver Transplant

NCT05477277 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-15

No results posted yet for this study

Summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Conditions

  • End Stage Liver DIsease
  • Sarcopenia
  • Sarcopenic Obesity
  • Cirrhosis

Interventions

DIAGNOSTIC_TEST

MAsS

Add MAsS to standard of care MRI scan

Sponsors & Collaborators

  • Amra Medical AB

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Elizabet Carey, MD · Mayo Cinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-02
Primary Completion
2026-07-01
Completion
2027-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05477277 on ClinicalTrials.gov